Drug discovery is being redefined as AI, machine learning, and digital platforms transform everything from target identification to clinical trials. Breakthroughs now hinge not only on experimental capability, but on the ability to integrate, interpret, and act on complex, multi-modal data at scale.
From AI-driven small molecule discovery to cell and gene therapy innovation, patient-first trial design, and quantum computing for drug development-the life sciences industry is entering an era where data readiness dictates scientific velocity. The winners will be those who bridge the gap between siloed datasets and high-impact decision-making.
Elucidata helps pharma, biotech, and diagnostics teams make that leap. Our AI-powered data solutions harmonize multi-omics and clinical datasets-making them clean, contextualized, compliant, and ready for advanced analytics, machine learning, or regulatory submissions. Our Co-founder and CTO Swetabh Pathak will be in Barcelona to share how we’re solving one of the biggest bottlenecks in drug discovery: getting data AI-ready at scale.
%201.svg){kind=icon}
At the event, we will be talking all about:
- Digital Innovation in Discovery
- LLM/AI for drug discovery and data curation
- AI/ML integration with genomics, protein prediction, and lab operations
- Quantum-accelerated screening & biomarker-driven pipelines
- Generative AI & explainable AI (XAI) in drug discovery and trial design
- Building interoperable data ecosystems for discovery platforms
Meet the Expert of this discussion
Meet our Co-founder and CEO at the event
Please check your inbox shortly!
.svg)
.svg)
.svg)
info@elucidata.io
%201%20(1).svg)
%20(1).svg)
%201%20(1).svg)
.svg)